In this dataset, a record needs both a mechanistic, hybrid or digital-twin process model and a claim addressing operational concerns like parameter identifiability, model validation, prediction horizon, scale transfer, real-time deployment or uncertainty propagation. A mechanistic model alone, without any of that operational machinery, would not be classified here. This dual requirement is why the technology composition spans control systems, AI computing and bioreactor hardware rather than sitting in one IPC class.

The ranking covers 100 companies counted in records, with the leading assignee holding 31 records and a sharp drop-off to 12 records at fifth place. The top 5 assignees combined account for 42.2% of all 237 records in scope, and the top 10 reach 58.2%, meaning a substantial share of filings still sits outside the leading names. The mix includes industrial-automation suppliers, pharmaceutical manufacturers and process-control incumbents rather than a single dominant industry.

Filings moved from 25 in 2021 to 24 in 2024, a -4% change, which reads as roughly flat rather than growing or shrinking. The apparent peak of 28 in 2025 should be treated cautiously because publication typically lags filing by about 18 months, so later years are always undercounted at the point of measurement. The honest read is that 2021-2024 growth has plateaued, not that the field is declining.